Tell A Colleague About The WIDE Program | Worldwide Initiative To Develop Everolimus
   
WIDE Program: Worldwide Initiative to Develop Everolimus
Print This Page   Email This Page
 
Novartis Oncology
Search :
 

Tell a Colleague about The WIDE Program
   » Home » Tell a Colleague
 

Thank You for Recommending The WIDE Program!
 
If you have a colleague that may be interested in learning about The WIDE Program (Worldwide Initiative to Develop Everolimus), you may send him or her a customized letter with drug and clinical trial details.

To send a letter about the WIDE Program to a colleague, fill in the following form and click "Send".

*Asterisk designates required field.
From:
Title:
*Full Name:
*E-mail:
To:
Title:
*Full Name:
*E-mail:
  Send Form to a Colleague
 
Disclaimer : These are investigational studies; there is no guarantee that everolimus will become commercially available for these indications
 
Disclaimer : This is an international web site for the The WIDE Program™ providing general information for healthcare professionals from all countries. The information on this site is not country-specific and may contain information that is different from where you practice. Please contact your local Novartis Medical Scientific Liaison for the latest information specific to your country.
Home | Renal Cell Carcinoma - RCC | Breast Cancer | Lymphoma - MCL & DLBCL | Tuberous Sclerosis Complex - TSC
Hepatocellular Carcinoma - HCC | Gastric Cancer | About Novartis | Tell a Colleague
Contact Us | Site Map | Terms of Use | Privacy Policy © 2010 Novartis AG